The Compliance Program Director – Sapin II Law is responsible for leading and developing the Group’s anti-corruption program, ensuring its alignment with the requirements of the Sapin II Law, the recommendations of the French Anti-Corruption Agency (AFA), international standards (FCPA, UKBA, etc.), and applicable reference standards (ISO 37001).
Under the leadership of the Group Chief Compliance Officer, the incumbent plays a major and active role within the Compliance Leadership Team, supporting all initiatives aimed at strengthening integrity, corruption prevention, and an ethical culture across the Group.
The incumbent also helps structure the Compliance Department, its operating model, governance, and priorities, in order to establish a robust, clearly defined function that delivers lasting value to the organization.
It should be noted that the whistleblowing system is overseen by the Chief Compliance Officer, while third-party assessments are managed by another team within the Department.
Code of Conduct: Support the updating of the Code and its rollout across the Group.
Corruption risk mapping: Support the finalization of the ongoing risk-mapping update.
Accounting controls: Support the Finance Department in its initiatives.
Training: Define the framework for developing new training courses and updates, define the Group’s training rollout strategy, and organize monitoring and renewal.
Disciplinary framework: Monitor implementation of the disciplinary framework and recommend any appropriate measures.
Internal control: Organize, support, and optimize monitoring activities at headquarters level; support initiatives carried out internationally; and organize global consolidation.
Whatever your area of expertise, your work within the Servier Group helps advance therapeutic progress for the benefit of patients. You will be part of teams recognized for their scientific excellence and reach your full potential in a professional environment that encourages you to develop yourself. Tailor-made onboarding journeys, mobility opportunities, quality trainings, responsible management, team spirit... All this and more in a workplace focused on your well-being.
At Servier, we are committed to therapeutic progress to serve patient needs. We put the diversity of our employees as a source of richness for the fulfillment of this vocation.

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle.
As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D.
Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion.
--
To report a suspected adverse event with a Servier drug, please visit servier.com